GWPH - GW Pharmaceuticals plc

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 55.25B
Enterprise Value 34.76B
Trailing P/E N/A
Forward P/E 1-73.03
PEG Ratio (5 yr expected) 10.84
Price/Sales (ttm)83.55
Price/Book (mrq)8.20
Enterprise Value/Revenue 375.83
Enterprise Value/EBITDA 6-17.90

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Mar 31, 2019

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-440.09%

Management Effectiveness

Return on Assets (ttm)N/A
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)62.82M
Revenue Per Share (ttm)2.02
Quarterly Revenue Growth (yoy)1,190.60%
Gross Profit (ttm)-19.8M
EBITDA -266.22M
Net Income Avi to Common (ttm)-268.23M
Diluted EPS (ttm)-8.61
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)521.67M
Total Cash Per Share (mrq)16.98
Total Debt (mrq)37.13M
Total Debt/Equity (mrq)5.80
Current Ratio (mrq)7.81
Book Value Per Share (mrq)20.83

Cash Flow Statement

Operating Cash Flow (ttm)-290.82M
Levered Free Cash Flow (ttm)N/A

Trading Information

Stock Price History

Beta (3Y Monthly) 2.37
52-Week Change 316.99%
S&P500 52-Week Change 34.25%
52 Week High 3196.00
52 Week Low 390.14
50-Day Moving Average 3177.31
200-Day Moving Average 3152.36

Share Statistics

Avg Vol (3 month) 3394.72k
Avg Vol (10 day) 3266.95k
Shares Outstanding 530.72M
Float 29.77M
% Held by Insiders 10.62%
% Held by Institutions 181.95%
Shares Short (May 31, 2019) 43.44M
Short Ratio (May 31, 2019) 46.48
Short % of Float (May 31, 2019) 4N/A
Short % of Shares Outstanding (May 31, 2019) 410.51%
Shares Short (prior month Apr 30, 2019) 43.15M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A